A combination of urinary biomarkers for tubular and cortical tubular damage, ganglioside M2 activator protein (GM2AP), and tail-less complex polypeptide-1 eta subunit (TCP1-eta), respectively, predicted recovery from AKI with a success rate of around 80% [61]. Here, GM2A is linked to acute kidney injury.